Reducing carbon impact of inhalers
Find out about the carbon impact of different inhaler types and more about the Ellipta device on our device & dosing page.
A lower cost (at £44.50) than commonly prescribed multiple inhaler triple therapies.1,2
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441.
© 2020 GSK Group of Companies or its licensor
Trademarks are the property of their respective owners
Trelegy Ellipta was developed in collaboration with
PM-GB-FVU-WCNT-200006 | February 2021